Article Information
History
- May 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Carla S. Walti, MD1,
- Andrea N. Loes, PhD2,3,
- Kiel Shuey, MS4,
- Elizabeth M. Krantz, MS1,
- Jim Boonyaratanakornkit, MD, PhD1,4,
- Jacob Keane-Candib, BS1,
- Tillie Loeffelholz, BS1,
- Caitlin R. Wolf, BS4,
- Justin J. Taylor, PhD1,
- Rebecca A. Gardner, MD5,6,7,
- Damian J. Green, MD4,5,
- Andrew J. Cowan, MD4,5,
- David G. Maloney, MD, PhD4,5,
- Cameron J. Turtle, MBBS, PhD4,5,
- Steven A. Pergam, MD, MPH1,4,5,
- Helen Y. Chu, MD, MPH4,
- Jesse D. Bloom, PhD2,3,8,9 and
- Joshua A. Hill, MD1,4,5,*
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 2Basic Science Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 3Howard Hughes Medical Institute, Seattle, WA, USA
- 4Department of Medicine, University of Washington, Seattle, WA, USA
- 5Clinical Research Division and Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 6Seattle Children’s Hospital, Seattle, WA, USA
- 7Department of Pediatrics, University of Washington, Seattle, WA, USA
- 8Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
- 9Department of Genome Sciences, University of Washington, Seattle, WA, USA
- ↵*Contact information for corresponding author
Joshua A. Hill, MD, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N. E4-100, Seattle, WA 98109-1024, USA, Email: jahill3{at}fredhutch.org
Posted May 11, 2021.
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy
